An integrated national scale SARS-CoV-2 genomic surveillance network.
COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk
;
(2020)
An integrated national scale SARS-CoV-2 genomic surveillance network.
The Lancet Microbe, 1 (3).
e99-e100.
ISSN 2666-5247
DOI: 10.1016/S2666-5247(20)30054-9
The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
-
picture_as_pdf - Aanensen-etal-2020-An-integrated-national-scale-SARS-CoV-2-genomic-surveillance-network.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads